TECLens and SERVImed Industrial have entered into a partnership aimed at developing a combination product to treat keratoconus, according to a press release.
The product will consist of TECLens’ CXLens cross-linking system for corneal remodeling and SERVImed’s transepithelial Ribocross riboflavin formulation, the release said.
“The combination of SERVImed’s proven Ribocross and TECLens’ proven CXLens will provide patients with a comfortable, noninvasive alternative to the treatment of ectatic disorders. Unlike any other cross-linking system, CXLens can treat both
Uncategorized